Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
37587 | 54 | 28.1 | 73% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
213 | 3 | BURNS//CRITICAL CARE MEDICINE//SEPSIS | 51408 |
3412 | 2 | PENTOXIFYLLINE//PROPENTOFYLLINE//BUFLOMEDIL | 1593 |
37587 | 1 | IBUDILAST//CAS 50847 11 5//3 ISOBUTYRYL 2 ISOPROPYLPYRAZOLO1 5 APYRIDINE PHARMACOLOGY | 54 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | IBUDILAST | authKW | 7495307 | 48% | 51% | 26 |
2 | CAS 50847 11 5 | authKW | 753967 | 4% | 67% | 2 |
3 | 3 ISOBUTYRYL 2 ISOPROPYLPYRAZOLO1 5 APYRIDINE PHARMACOLOGY | authKW | 565476 | 2% | 100% | 1 |
4 | IBUDILAST PROSTANOID | authKW | 565476 | 2% | 100% | 1 |
5 | KC 404 PHARMACOLOGY | authKW | 565476 | 2% | 100% | 1 |
6 | KETASR | authKW | 565476 | 2% | 100% | 1 |
7 | KYORIN SCOTLAND S | address | 565476 | 2% | 100% | 1 |
8 | MIXED PHOSPHODIESTERASE PDE 3 4 INHIBITOR | authKW | 565476 | 2% | 100% | 1 |
9 | NEURONEXT | address | 565476 | 2% | 100% | 1 |
10 | 221 MIYAMA | address | 282737 | 2% | 50% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 569 | 59% | 0% | 32 |
2 | Neurosciences | 55 | 20% | 0% | 11 |
3 | Clinical Neurology | 53 | 15% | 0% | 8 |
4 | Peripheral Vascular Diseases | 15 | 6% | 0% | 3 |
5 | Chemistry, Medicinal | 14 | 6% | 0% | 3 |
6 | Allergy | 7 | 2% | 0% | 1 |
7 | Pathology | 6 | 4% | 0% | 2 |
8 | Toxicology | 5 | 4% | 0% | 2 |
9 | Physiology | 3 | 4% | 0% | 2 |
10 | Medicine, Research & Experimental | 2 | 4% | 0% | 2 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | KYORIN SCOTLAND S | 565476 | 2% | 100% | 1 |
2 | NEURONEXT | 565476 | 2% | 100% | 1 |
3 | 221 MIYAMA | 282737 | 2% | 50% | 1 |
4 | CEREBRAL CIRCULAT | 188491 | 2% | 33% | 1 |
5 | NITR | 80781 | 2% | 14% | 1 |
6 | JOINT THER IES INTRACTABLE DIS | 70683 | 2% | 13% | 1 |
7 | BEHAV ADDICT MED | 51405 | 2% | 9% | 1 |
8 | KLIN SRBIJE | 37697 | 2% | 7% | 1 |
9 | MED NORTH | 35340 | 2% | 6% | 1 |
10 | BIOEQUIVALENCE BRIDGING STUDY | 18847 | 2% | 3% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MULTIPLE SCLEROSIS | 9115 | 6% | 1% | 3 |
2 | NEURON GLIA BIOLOGY | 2928 | 2% | 1% | 1 |
3 | GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM | 1974 | 6% | 0% | 3 |
4 | BALKAN MEDICAL JOURNAL | 1364 | 2% | 0% | 1 |
5 | CARDIOVASCULAR DRUG REVIEWS | 1344 | 2% | 0% | 1 |
6 | JOURNAL OF PAIN RESEARCH | 1313 | 2% | 0% | 1 |
7 | ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE | 1000 | 4% | 0% | 2 |
8 | FOLIA NEUROPATHOLOGICA | 668 | 2% | 0% | 1 |
9 | GENERAL PHARMACOLOGY | 661 | 2% | 0% | 1 |
10 | FOLIA PHARMACOLOGICA JAPONICA | 513 | 2% | 0% | 1 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | IBUDILAST | 7495307 | 48% | 51% | 26 | Search IBUDILAST | Search IBUDILAST |
2 | CAS 50847 11 5 | 753967 | 4% | 67% | 2 | Search CAS+50847+11+5 | Search CAS+50847+11+5 |
3 | 3 ISOBUTYRYL 2 ISOPROPYLPYRAZOLO1 5 APYRIDINE PHARMACOLOGY | 565476 | 2% | 100% | 1 | Search 3+ISOBUTYRYL+2+ISOPROPYLPYRAZOLO1+5+APYRIDINE+PHARMACOLOGY | Search 3+ISOBUTYRYL+2+ISOPROPYLPYRAZOLO1+5+APYRIDINE+PHARMACOLOGY |
4 | IBUDILAST PROSTANOID | 565476 | 2% | 100% | 1 | Search IBUDILAST+PROSTANOID | Search IBUDILAST+PROSTANOID |
5 | KC 404 PHARMACOLOGY | 565476 | 2% | 100% | 1 | Search KC+404+PHARMACOLOGY | Search KC+404+PHARMACOLOGY |
6 | KETASR | 565476 | 2% | 100% | 1 | Search KETASR | Search KETASR |
7 | MIXED PHOSPHODIESTERASE PDE 3 4 INHIBITOR | 565476 | 2% | 100% | 1 | Search MIXED+PHOSPHODIESTERASE+PDE+3+4+INHIBITOR | Search MIXED+PHOSPHODIESTERASE+PDE+3+4+INHIBITOR |
8 | NON NMDA GLUTAMATE RECEPTORS | 251320 | 4% | 22% | 2 | Search NON+NMDA+GLUTAMATE+RECEPTORS | Search NON+NMDA+GLUTAMATE+RECEPTORS |
9 | CEREBRAL VASODILATOR | 188491 | 2% | 33% | 1 | Search CEREBRAL+VASODILATOR | Search CEREBRAL+VASODILATOR |
10 | KC 404 | 188491 | 2% | 33% | 1 | Search KC+404 | Search KC+404 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | BARKHOF, F , HULST, HE , DRULOVIC, J , UITDEHAAG, BMJ , MATSUDA, K , LANDIN, R , (2010) IBUDILAST IN RELAPSING-REMITTING MULTIPLE SCLEROSIS A NEUROPROTECTANT?.NEUROLOGY. VOL. 74. ISSUE 13. P. 1033 -1040 | 10 | 56% | 57 |
2 | LEE, JY , CHO, E , KO, YE , KIM, I , LEE, KJ , KWON, SU , KANG, DW , KIM, JS , (2012) IBUDILAST, A PHOSPHODIESTERASE INHIBITOR WITH ANTI-INFLAMMATORY ACTIVITY, PROTECTS AGAINST ISCHEMIC BRAIN INJURY IN RATS.BRAIN RESEARCH. VOL. 1431. ISSUE . P. 97-106 | 14 | 42% | 7 |
3 | GIBSON, LCD , HASTINGS, SF , MCPHEE, I , CLAYTON, RA , DARROCH, CE , MACKENZIE, A , MACKENZIE, FL , NAGASAWA, M , STEVENS, PA , MACKENZIE, SJ , (2006) THE INHIBITORY PROFILE OF IBUDILAST AGAINST THE HUMAN PHOSPHODIESTERASE ENZYME FAMILY.EUROPEAN JOURNAL OF PHARMACOLOGY. VOL. 538. ISSUE 1-3. P. 39-42 | 12 | 44% | 55 |
4 | YOON, H , CHO, HY , LEE, YB , (2010) DETERMINATION OF IBUDILAST IN HUMAN SERUM BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY FOR PHARMACOKINETIC STUDY.BIOMEDICAL CHROMATOGRAPHY. VOL. 24. ISSUE 3. P. 324-328 | 5 | 83% | 1 |
5 | GOODMAN, AD , GYANG, T , SMITH, AD , (2016) IBUDILAST FOR THE TREATMENT OF MULTIPLE SCLEROSIS.EXPERT OPINION ON INVESTIGATIONAL DRUGS. VOL. 25. ISSUE 10. P. 1231 -1237 | 13 | 26% | 0 |
6 | WANG, H , MEI, ZL , ZHONG, KL , HU, M , LONG, Y , MIAO, MX , LI, N , YAN, TH , HONG, H , (2014) PRETREATMENT WITH ANTIASTHMATIC DRUG IBUDILAST AMELIORATES A BETA(1-42)-INDUCED MEMORY IMPAIRMENT AND NEUROTOXICITY IN MICE.PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR. VOL. 124. ISSUE . P. 373 -379 | 13 | 27% | 1 |
7 | LEDEBOER, A , LIU, TY , SHUMILLA, JA , MAHONEY, JH , VIJAY, S , GROSS, MI , VARGAS, JA , SULTZBAUGH, L , CLAYPOOL, MD , SANFTNER, LM , ET AL (2006) THE GLIAL MODULATORY DRUG AV(411) ATTENUATES MECHANICAL ALLODYNIA IN RAT MODELS OF NEUROPATHIC PAIN.NEURON GLIA BIOLOGY. VOL. 2. ISSUE . P. 279 -291 | 15 | 25% | 11 |
8 | HOSHINO, T , IKEDA, T , (2002) INHIBITORY EFFECT OF IBUDILAST ON URINARY ALBUMIN EXCRETION IN TYPE 2 DIABETES MELLITUS WITH MICROALBUMINURIA.NEPHRON. VOL. 90. ISSUE 2. P. 154 -157 | 7 | 54% | 4 |
9 | KANEDA, T , KONNO, Y , URAKAWA, N , NAKAJYO, S , SHIMIZU, K , (2007) IBUDILAST-INDUCED DECREASES IN CYTOSOLIC CA2+ LEVEL AND CONTRACTION IN RAT AORTA.JOURNAL OF PHARMACOLOGICAL SCIENCES. VOL. 104. ISSUE 4. P. 311-318 | 9 | 36% | 1 |
10 | KISHI, Y , OHTA, S , KASUYA, N , SAKITA, S , ASHIKAGA, T , ISOBE, M , (2001) IBUDILAST: A NON-SELECTIVE PDE INHIBITOR WITH MULTIPLE ACTIONS ON BLOOD CELLS AND THE VASCULAR WALL.CARDIOVASCULAR DRUG REVIEWS. VOL. 19. ISSUE 3. P. 215 -225 | 10 | 34% | 39 |
Classes with closest relation at Level 1 |